These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 38055276)

  • 21. Chronic kidney disease and statin eligibility.
    Vega GL; Wang J; Grundy SM
    J Clin Lipidol; 2021; 15(1):173-180. PubMed ID: 33191195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin use, intensity, and 3-year clinical outcomes among older patients with coronary artery disease.
    O'Brien EC; Wu J; Schulte PJ; Christian A; Laskey W; Bhatt DL; Peterson ED; Hernandez AF; Fonarow GC
    Am Heart J; 2016 Mar; 173():27-34. PubMed ID: 26920593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subclinical Atherosclerosis, Statin Eligibility, and Outcomes in African American Individuals: The Jackson Heart Study.
    Shah RV; Spahillari A; Mwasongwe S; Carr JJ; Terry JG; Mentz RJ; Addison D; Hoffmann U; Reis J; Freedman JE; Lima JAC; Correa A; Murthy VL
    JAMA Cardiol; 2017 Jun; 2(6):644-652. PubMed ID: 28315622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association Between Historical Neighborhood Redlining and Cardiovascular Outcomes Among US Veterans With Atherosclerotic Cardiovascular Diseases.
    Deo SV; Motairek I; Nasir K; Mentias A; Elgudin Y; Virani SS; Rajagopalan S; Al-Kindi S
    JAMA Netw Open; 2023 Jul; 6(7):e2322727. PubMed ID: 37432687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statin use among Veterans with dialysis-dependent chronic kidney disease.
    Markossian TW; Kramer HJ; Burge NJ; Pacold IV; Leehey DJ; Huo Z; Schneider J; Ling B; Stroupe KT
    Hemodial Int; 2019 Apr; 23(2):206-213. PubMed ID: 30779455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
    Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Hypercholesterolemia and Statin Exposure on Survival in a Large National Cohort of Patients With Cirrhosis.
    Kaplan DE; Serper MA; Mehta R; Fox R; John B; Aytaman A; Baytarian M; Hunt K; Albrecht J; Njei B; Taddei TH;
    Gastroenterology; 2019 May; 156(6):1693-1706.e12. PubMed ID: 30660733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Statin initiation and risk of incident kidney disease in patients with diabetes.
    Zhou S; Su L; Xu R; Li Y; Chen R; Cao Y; Gao P; Zhang X; Luo F; Gao Q; An S; Cai W; Lin L; Xu H; Liu B; Weng J; Chunbo C; Liu H; Yang Q; Li H; Kong Y; Li G; Wan Q; Zha Y; Hu Y; Xu G; Shi Y; Zhou Y; Su G; Tang Y; Gong M; Xu X; Nie S
    CMAJ; 2023 May; 195(21):E729-E738. PubMed ID: 37247880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statins for primary prevention of cardiovascular events and mortality in old and very old adults with and without type 2 diabetes: retrospective cohort study.
    Ramos R; Comas-Cufí M; Martí-Lluch R; Balló E; Ponjoan A; Alves-Cabratosa L; Blanch J; Marrugat J; Elosua R; Grau M; Elosua-Bayes M; García-Ortiz L; Garcia-Gil M
    BMJ; 2018 Sep; 362():k3359. PubMed ID: 30185425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of statin therapy on cerebrovascular and renal outcomes in patients with predialysis advanced chronic kidney disease and dyslipidemia.
    Chung CM; Lin MS; Hsu JT; Hsiao JF; Chang ST; Pan KL; Lin CL; Lin YS
    J Clin Lipidol; 2017; 11(2):422-431.e2. PubMed ID: 28502499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin Eligibility for Primary Prevention of Cardiovascular Disease According to 2021 European Prevention Guidelines Compared With Other International Guidelines.
    Mortensen MB; Tybjærg-Hansen A; Nordestgaard BG
    JAMA Cardiol; 2022 Aug; 7(8):836-843. PubMed ID: 35793078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.
    Leibowitz M; Karpati T; Cohen-Stavi CJ; Feldman BS; Hoshen M; Bitterman H; Suissa S; Balicer RD
    JAMA Intern Med; 2016 Aug; 176(8):1105-13. PubMed ID: 27322095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer.
    Emilsson L; García-Albéniz X; Logan RW; Caniglia EC; Kalager M; Hernán MA
    JAMA Oncol; 2018 Jan; 4(1):63-70. PubMed ID: 28822996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events.
    Zhan S; Tang M; Liu F; Xia P; Shu M; Wu X
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012502. PubMed ID: 30480766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in statin prescription among veterans with HIV and known atherosclerotic cardiovascular disease.
    Erqou S; Papaila A; Halladay C; Ge A; Liu MA; Jiang L; Lally M; Menon A; Shah NR; Miech E; Virani SS; Zullo AR; Shireman TI; Longenecker CT; Ross D; Sullivan JL; Wu WC; Rudolph JL
    Am Heart J; 2022 Jul; 249():12-22. PubMed ID: 35318028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal changes in statin prescription and intensity at discharge and impact on outcomes in patients with newly diagnosed atherosclerotic cardiovascular disease-Real-world experience within a large integrated health care system: The IMPRES study.
    Anderson JL; Knowlton KU; May HT; Bair TL; Armstrong SO; Lappé DL; Muhlestein JB
    J Clin Lipidol; 2018; 12(4):1008-1018.e1. PubMed ID: 29703626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Palmer SC; Navaneethan SD; Craig JC; Perkovic V; Johnson DW; Nigwekar SU; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD005019. PubMed ID: 24470059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
    Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
    JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis.
    Patel J; Pallazola VA; Dudum R; Greenland P; McEvoy JW; Blumenthal RS; Virani SS; Miedema MD; Shea S; Yeboah J; Abbate A; Hundley WG; Karger AB; Tsai MY; Sathiyakumar V; Ogunmoroti O; Cushman M; Savji N; Liu K; Nasir K; Blaha MJ; Martin SS; Al Rifai M
    JAMA Cardiol; 2021 Oct; 6(10):1161-1170. PubMed ID: 34259820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Statin Therapy Initiation With Diabetes Progression: A Retrospective Matched-Cohort Study.
    Mansi IA; Chansard M; Lingvay I; Zhang S; Halm EA; Alvarez CA
    JAMA Intern Med; 2021 Dec; 181(12):1562-1574. PubMed ID: 34605849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.